Literature DB >> 6576544

Morphometric studies on nuclei in smears of fine needle aspirates from oxyphilic tumors of the thyroid.

L Bondeson, A G Bondeson, K Lindholm, O Ljungberg, S Tibblin.   

Abstract

Morphometry was applied to smears of fine needle aspirates from 26 oxyphilic thyroid neoplasms. Thirteen tumors were considered benign as judged from histologic findings and clinical follow-up for 2 to 20 years after the operation. Thirteen tumors were considered malignant histologically; four of these had proven metastases. In each case the mean and standard deviation of the projected nuclear area were calculated from 200 nuclei in the smear. Our results indicate that morphometric estimation of mean nuclear size and/or degree of anisokaryosis is of no practical value in distinguishing between benign and malignant thyroid neoplasms of the oxyphilic type.

Entities:  

Mesh:

Year:  1983        PMID: 6576544

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  5 in total

Review 1.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

Review 2.  The study of endocrine tumors by flow and image cytometry.

Authors:  Ingrid Zbieranowski; David Murray
Journal:  Endocr Pathol       Date:  1992-06       Impact factor: 3.943

3.  Morphometric analysis of thyroid cell aspirates.

Authors:  R G Wright; H Castles; R H Mortimer
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

Review 4.  Update on special techniques in routine cytopathology.

Authors:  I D Buley
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

5.  Value of quantitative nucleolar features in the preoperative cytological diagnosis of follicular neoplasias of the thyroid.

Authors:  R Montironi; A Braccischi; M Scarpelli; G Matera; R Alberti
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.